Nurse Practitioner, Family · Petoskey, MI
NPI
1841732617
Since 2016
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
560 W Mitchell St, Suite M40
Petoskey, MI, 49770
Phone (231) 487-2391
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$2.8M
1,671 prescriptions
Company payments, 2025
$1,213
From 11 companies
Medicare prescription drug claims, 2024
In 2024, the drug Dawn Ebersole prescribed most often to Medicare patients was Linzess (Linaclotide), with 173 prescriptions and refills. In total Dawn Ebersole wrote 1,671 Medicare prescriptions that cost $2.8M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-11-10.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Linzess Linaclotide | 173 | 228 | 47 | $118K |
| Omeprazole Generic | 141 | 289 | 49 | $2,143 |
| Pantoprazole Sodium Generic | 123 | 270 | 46 | $2,323 |
| Budesonide Dr Budesonide | 105 | 157 | 49 | $13K |
| Azathioprine Generic | 94 | 240 | 25 | $9,234 |
| Lubiprostone Generic | 87 | 121 | 29 | $21K |
| Mesalamine Generic | 74 | 159 | 25 | $77K |
| Sucralfate Generic | 59 | 81 | 20 | $1,302 |
| Ursodiol Generic | 51 | 101 | Under 11 | $14K |
| Cholestyramine Cholestyramine (With Sugar) | 44 | 48 | 17 | $2,801 |
| Stelara Ustekinumab | 43 | 70 | Under 11 | $1.3M |
| Rinvoq Upadacitinib | 40 | 40 | Under 11 | $260K |
| Creon Lipase/Protease/Amylase | 34 | 50 | Under 11 | $67K |
| Prednisone Generic | 31 | 41 | 13 | $326 |
| Sulfasalazine Generic | 30 | 70 | 11 | $1,744 |
Brand drugs: 615 claims; generic drugs: 1,056 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Dawn Ebersole $1,213 ($1,213 in general payments such as food, travel and fees) from 11 companies. The largest payer was Gilead Sciences, Inc. with $187.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 2 | $187 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 1 | $125 |
| Ardelyx, Inc. ARDX | 1 | $124 |
| Abbvie Inc. ABBV | 1 | $122 |
| Intercept Pharmaceuticals, Inc. | 1 | $121 |
| Janssen Scientific Affairs, LLC JNJ | 1 | $112 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 5 | $111 |
| Aimmune Therapeutics, Inc. | 1 | $104 |
| Madrigal Pharmaceuticals MDGL | 1 | $91.74 |
| Genzyme Corporation SNY | 1 | $73.92 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.